Citations 3
Two phase III studies comparing 6 months of either mFOLFOX6 or XELOX with 3 months of the same regimen as adjuvant chemotherapy in patients with completely resected stage III colon cancer (ACHIEVE) or high-risk stage II colon cancer (ACHIEVE-2).
Watanabe, Toshiaki , Ohtsu, Atsushi , Yamazaki, Kentaro , Sunami, Eiji , Shirao, Kuniaki , Satō, Atsushi, Morita, Satoshi , Yamanaka, Takeharu , Sakamoto, Junichi , Saji, Shigetoyo, Yoshino, Takayuki , Mori, Masaki , Mizushima, Tsunekazu , Grothey, Axel , Sargent, Daniel J.
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS3655-TPS3655
Association of chemotherapy induced neutropenia at 1-month mark (CIN-1-month) and overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A Cohort study.
Shitara, Kohei , Ohtsu, Atsushi , Ramanathan, Ramesh K., Höchster, Howard S. , Kasi, Pashtoon Murtaza , Kotani, Daisuke , Cecchini, Michael , Grothey, Axel , Yoshino, Takayuki
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e15124-e15124
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
Fuchs, Charles S. , Doi, Toshihiko , Jang, Raymond Woo-Jun, Muro, Kei , Machado, Manuela , Sun, Weijing , Jalal, Shadia I. , Metges, Jean-Phillipe, Garrido, Marcelo , Golan, Talia , Mandalà, Mario , Catenacci, Daniel V.T. , Ohtsu, Atsushi , Shitara, Kohei , Geva, Ravit , Bleeker, Jonathan , Ko, Andrew H. , Philip, Philip, Enzinger, Peter C. , Levitan, Diane, Wang, Jiangdian, Rosales, Minori Koshiji, Dalal, Rita P., Yoon, Harry H. , Satoh, Taroh , Shah, Manish A , Metges, Jean‐Philippe , Wainberg, Zev A. , Ku, Geoffrey , Bang, Yung‐Jue
JAMA Oncology | March 15, 2018 | Volume: 4 | Issue: 5 | Pages: e180013